J.P. Morgan Sees U.S. Humanoid Robot Output Hitting 400,000 by 2030

J.P. Morgan expects U.S. humanoid robot production to reach 300,000–400,000 units by 2030 and about 1.5 million units by 2035, according to a Reuters report published on November 12, 2026. The forecast marks a decisive shift in how Wall Street values the sector: the industry is moving from demonstrations to commercial deployment, and production scale now matters as much as task performance.

The numbers anchor a simple argument. Commercial adoption depends on two things happening at once — robots that can do the work, and manufacturers that can supply them in sufficient numbers. J.P. Morgan's projection treats both as open questions, and its analysis splits accordingly between demand-side economics and supply-side constraints.

What is driving adoption?

The brokerage identified three adoption drivers: labor shortages, improving economics, and rising production capacity. The target sectors are manufacturing, logistics, and warehousing, where businesses are looking to automate repetitive tasks. That is a deliberate framing. Humanoids compete least badly in environments built for human bodies, and repetitive industrial work is where the financial case closes first.

The economics are approaching a tipping point. J.P. Morgan estimated that humanoid robot costs are nearing parity with labor costs. Multi-shift deployment — operating robots across more than one work shift — could generate about $100,000 in annual savings per customer.

That savings figure does the heavy lifting in the business case. A robot that works one shift competes with one worker. A robot that works two or three shifts competes with several, without proportional increases in cost. Utilization across shifts therefore becomes central to how customers evaluate a deployment, alongside the availability of human labor they are trying to supplement or replace.

Could policy accelerate U.S. production?

Policy may add a further incentive for domestic output. J.P. Morgan said the Trump administration's finding that imported robotics and industrial machinery pose national security risks could lead to tariffs or other measures to boost U.S. production.

That potential support complements the adoption drivers already in place. But the brokerage was explicit about its limits: policy does not remove the manufacturing and technology constraints embedded in the forecast. Tariffs can shift where robots are built. They cannot conjure the components, the training data, or the factory capacity that currently cap output.

How tight are the supply constraints?

Very. Most U.S. humanoid manufacturers other than Tesla are targeting annual production of 10,000–30,000 units, according to the brokerage. Those company-level targets reveal the arithmetic problem inside the aggregate forecast: reaching 300,000–400,000 units by 2030 requires a manyfold expansion across the industry, not incremental growth from today's baselines.

The constraints are specific. Deployment is limited by hardware, AI training data, compute, and production capacity. The brokerage's diagnosis was blunt:

"Near-term progress remains supply constrained, with a few binding bottlenecks: hands, actuators, the brain, and production capacity."

Four bottlenecks, one sentence. Hands and actuators are physical components — dexterous manipulation and the motors that drive movement remain hard to manufacture at scale. "The brain" covers the AI systems and the compute and data needed to train them. Production capacity is the factory problem. Each limit sits on a different point in the chain, from the robot's physical parts to the resources used to develop its intelligence to the plants required to build it. Supply, in J.P. Morgan's reading, is the immediate constraint on adoption — not demand, not price, not customer willingness.

Where does the near-term value sit?

Component suppliers. J.P. Morgan views them as the biggest near-term opportunity and expects the market for key parts — actuators, motors, and vision systems — to approach $30 billion by 2035.

The emphasis follows directly from the bottleneck list. If hands and actuators restrict how many robots manufacturers can deliver, then the companies that relieve those restrictions capture the first wave of value. The brokerage named its favored suppliers:

• Timken — bearings and motion-control components
• Robotis — actuators and robotic hardware
• Leader Drive — drive components
• Orbbec — 3D vision systems
• Cognex — machine vision

None of these are humanoid makers. They are the picks-and-shovels layer of the industry, positioned to benefit from output growth regardless of which robot platform wins.

Which robot makers lead the U.S. field?

Among U.S. humanoid manufacturers, J.P. Morgan highlighted five key players:

• Tesla's Optimus
• Agility Robotics' Digit
• Boston Dynamics' Atlas
• Figure AI's Figure robots
• Apptronik's Apollo

The brokerage expects value creation to shift over time toward robot makers and platform integrators. That sequencing matters for investors. Components first, platforms later. The suppliers capture value while output is the constraint; the robot makers and integrators capture it once supply loosens and commercial deployments scale.

Can supply catch up with the economics?

That is the central question the forecast poses. The demand side is comparatively solid: labor shortages are persistent, the per-customer savings case is quantified at roughly $100,000 per year under multi-shift operation, and policy may tilt the field toward domestic manufacturers. The supply side is not: four binding bottlenecks, most manufacturers targeting 10,000–30,000 units annually, and a 2030 target that implies steep factory expansion across the board.

The near-term opportunity, in J.P. Morgan's framing, lies in relieving component and capacity constraints — which is why suppliers like Timken and Cognex top its list. The longer-term value shift depends on robot makers and integrators converting expanded output into commercial deployments, at volumes approaching 1.5 million units by 2035. Whether the industry bridges the gap between a $30 billion component market and million-unit production is the question the next five years will answer.